In these patients, the investigational gene therapy AAV-hAQP1 has been well tolerated with no dose limiting toxicity and no serious adverse events ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2020/12/16/2146570/0/en/MeiraGTx-To-Present-Clinical-Program-Update-for-AAV-hAQP1-Treatment-of-Radiation-Induced-Xerostomia.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNF3kEmr1eNaWOJMbSqokItUOfKsdA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.